Form 4 for IMUX IMMUNIC, INC.
Accepted 2025-06-04 00:00:00 ET · period of report 2025-06-03 · accession 0001193805-25-000788 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-04 | 2025-05-30 | IMUX | Whaley Glenn | CFO | A - Grant | $0.56 | +25.0K | 50.5K | +98% | +$14.0K | |
| 2025-06-04 | 2025-06-03 | IMUX | Whaley Glenn | CFO | P - Purchase | $0.71 | +45.0K | 95.5K | +89% | +$31.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-30 | A | A | 25,000 | $0.56 | 50,510 | D | — | — | (F1) The Reporting Person (RP) is voluntarily reporting the acquisition of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c). (F2) In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 30, 2025. |
| 2 | Common | Common Stock | 2025-06-03 | P | A | 45,000 | $0.71 | 95,510 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7127 to $0.7134. The RP undertakes to provide to the Issuer, any securityholder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price. |